Concurso Abertos - Pilar II e III do Horizonte Europa
HORIZON-MISS-2027-02 - Supporting the implementation of the Cancer Mission
Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
HORIZON-MISS-2027-02-CANCER-03 (Forthcoming)
| Tipo de Ação | HORIZON Research and Innovation Actions (HORIZON-RIA) |
| Área(s) temática(s) | |
|
|
Datas
| Publicação | 12-12-2025 |
| Abertura | 10-02-2027 |
| Modo | |
| Fecho | 21-09-2027 00:00h |
Financiamento
24.000.000€
Ver a lista de tópicos
